U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H10ClFN2
Molecular Weight 260.694
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-(4-FLUOROBENZYL)-2-CHLOROBENZIMIDAZOLE

SMILES

FC1=CC=C(CN2C(Cl)=NC3=C2C=CC=C3)C=C1

InChI

InChIKey=PGXALMVNIRPELS-UHFFFAOYSA-N
InChI=1S/C14H10ClFN2/c15-14-17-12-3-1-2-4-13(12)18(14)9-10-5-7-11(16)8-6-10/h1-8H,9H2

HIDE SMILES / InChI

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Reversible anti-settlement activity against Amphibalanus (=Balanus) amphitrite, Bugula neritina, and Hydroides elegans by a nontoxic pharmaceutical compound, mizolastine.
2009-11
Patents

Patents

04634704
5
04695575
5
04835161
5
04839374
5
05461059
4
05922737
4
06110939
3
06211199
4
Name Type Language
1H-BENZIMIDAZOLE, 2-CHLORO-1-((4-FLUOROPHENYL)METHYL)-
Preferred Name English
1-(4-FLUOROBENZYL)-2-CHLOROBENZIMIDAZOLE
Systematic Name English
Code System Code Type Description
FDA UNII
572KOO4QPT
Created by admin on Mon Mar 31 20:39:40 GMT 2025 , Edited by admin on Mon Mar 31 20:39:40 GMT 2025
PRIMARY
CAS
84946-20-3
Created by admin on Mon Mar 31 20:39:40 GMT 2025 , Edited by admin on Mon Mar 31 20:39:40 GMT 2025
PRIMARY
EPA CompTox
DTXSID40233991
Created by admin on Mon Mar 31 20:39:40 GMT 2025 , Edited by admin on Mon Mar 31 20:39:40 GMT 2025
PRIMARY
PUBCHEM
3020241
Created by admin on Mon Mar 31 20:39:40 GMT 2025 , Edited by admin on Mon Mar 31 20:39:40 GMT 2025
PRIMARY
ECHA (EC/EINECS)
284-624-0
Created by admin on Mon Mar 31 20:39:40 GMT 2025 , Edited by admin on Mon Mar 31 20:39:40 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966